Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | HSD17B2 |
| Upstream (Parents) |
|---|
| (<<) ALK → HSD17B2 |
| (<<) CHST11 → HSD17B2 |
| (<<) CLEC2B → HSD17B2 |
| (<<) CSTB → HSD17B2 |
| (<<) ENO2 → HSD17B2 |
| (<<) FAM83A → HSD17B2 |
| (<<) FERMT1 → HSD17B2 |
| (<<) HDAC5 → HSD17B2 |
| (<<) IDI1 → HSD17B2 |
| (<<) PDK2 → HSD17B2 |
| (<<) PGK1 → HSD17B2 |
| Downstream (Children) |
|---|
| HSD17B2 → ARSA (>>) |
| HSD17B2 → FA2H (>>) |
| HSD17B2 → MPHOSPH6 (>>) |
| HSD17B2 → OVOL1 (>>) |
| HSD17B2 → PTMS (>>) |
| HSD17B2 → PYGL (>>) |
| HSD17B2 → SOX18 (>>) |
